NKTX Stock Price - Nkarta, Inc. logo

NKTX Stock Price

Nkarta, Inc.

$1.15
-$0.10(-8.00%)
31
Overall
60
Value
18
Tech
15
Quality
How is this score calculated?
Market Cap
$82.46M
Volume
811.11K
52W Range
$1.11 - $3.72
Target Price
$10.50

NKTX stock price is $1.15 (-8.00% on the day), giving Nkarta, Inc. a market cap of $82.46M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

NKTX Stock Overview

Price
$1.15
Previous close
$1.25
Open
$1.25
Market cap
$82.46M
52-week range
$1.10 - $3.72
1-year price target
$10.50
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
31

About Nkarta, Inc.

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

ABCD
1SymbolPriceChangeVol
2NKTX$1.15-8.0%811.11K
3
4
5
6

Get Nkarta, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.